Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John A Cairns

Showing results (1-10 of 104) with videos related to

Pageof 11
Sort By:
Polskie Archiwum Medycyny Wewnetrznej|September 18, 2012
Prevention of stroke and systemic embolization in atrial fibrillation: a Canadian perspectiveJohn A Cairns
American Journal of Therapeutics|February 1, 1995
Coronary ThrombolysisJohn A. Cairns
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|January 29, 2005
The Canadian Clinical Research Initiative: transforming Canadian clinical research capacityJohn A Cairns
Journal of the American College of Cardiology|August 1, 2006
Ranolazine: augmenting the antianginal armamentariumJohn A Cairns
American Heart Journal|September 7, 2016
Oral anticoagulant prescription for atrial fibrillation in the Veterans Administration Health System: National and international differencesJohn A Cairns
Annals of Internal Medicine|May 18, 2011
ACP journal club. CHA2DS2-VASc had better discrimination than CHADS2 for predicting risk for thromboembolism in atrial fibrillationJohn A Cairns
Annals of Internal Medicine|September 17, 2009
ACP Journal Club. In patients with atrial fibrillation, adding clopidogrel to aspirin reduced major vascular events but increased bleedingJohn A Cairns
European Heart Journal|March 26, 2016
The search for the ideal atrial fibrillation stroke risk prediction schema: is ATRIA a contender?John A Cairns
The Canadian Journal of Cardiology|August 13, 2013
Which oral anticoagulant for which atrial fibrillation patient: recent clinical trials and evidence-based choicesJohn A Cairns
Polskie Archiwum Medycyny Wewnetrznej|July 16, 2008
Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in preventive cardiology: which drug to use and what to expect in light of the ONTARGET trialJohn A Cairns
Pageof 11

Showing results (1-10 of 104) with videos related to

Sort By:
Pageof 11
Polskie Archiwum Medycyny Wewnetrznej|September 18, 2012
Prevention of stroke and systemic embolization in atrial fibrillation: a Canadian perspectiveJohn A Cairns
American Journal of Therapeutics|February 1, 1995
Coronary ThrombolysisJohn A. Cairns
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|January 29, 2005
The Canadian Clinical Research Initiative: transforming Canadian clinical research capacityJohn A Cairns
Journal of the American College of Cardiology|August 1, 2006
Ranolazine: augmenting the antianginal armamentariumJohn A Cairns
American Heart Journal|September 7, 2016
Oral anticoagulant prescription for atrial fibrillation in the Veterans Administration Health System: National and international differencesJohn A Cairns
Annals of Internal Medicine|May 18, 2011
ACP journal club. CHA2DS2-VASc had better discrimination than CHADS2 for predicting risk for thromboembolism in atrial fibrillationJohn A Cairns
Annals of Internal Medicine|September 17, 2009
ACP Journal Club. In patients with atrial fibrillation, adding clopidogrel to aspirin reduced major vascular events but increased bleedingJohn A Cairns
European Heart Journal|March 26, 2016
The search for the ideal atrial fibrillation stroke risk prediction schema: is ATRIA a contender?John A Cairns
The Canadian Journal of Cardiology|August 13, 2013
Which oral anticoagulant for which atrial fibrillation patient: recent clinical trials and evidence-based choicesJohn A Cairns
Polskie Archiwum Medycyny Wewnetrznej|July 16, 2008
Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in preventive cardiology: which drug to use and what to expect in light of the ONTARGET trialJohn A Cairns
Pageof 11